ArticleslgStudy

science

Olesoxime

Olesoxime is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Olesoxime rather than just read about it. In short: Olesoxime (TRO19622) is an experimental drug formerly under development by the now-defunct French company Trophos as a treatment for a range of neuromuscular disorders. It has a cholesterol-like structure and belongs to the cholesterol-oxime family of mitochondrial pore modulators.

Olesoxime — main illustration
Olesoxime — illustration

Key takeaways

  • Olesoxime belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Olesoxime to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Olesoxime from memory before moving on to harder problems.

Reference excerpt

Olesoxime (TRO19622) is an experimental drug formerly under development by the now-defunct French company Trophos as a treatment for a range of neuromuscular disorders. It has a cholesterol-like structure and belongs to the cholesterol-oxime family of mitochondrial pore modulators.

Research In preclinical studies, the compound displayed neuroprotective properties by promoting the function and survival of neurons and other cell types under disease-relevant stress conditions. It did so through interactions with two components of the mitochondrial permeability transition pore (mPTP), VDAC and TSPO. In preclinical studies on Huntington's disease, the disease-attenuating effects of olesoxime were attributed to modulating the activity of calcium-dependent proteases called calpains. A 2009–2011 phase 3 clinical trial in amyotrophic lateral sclerosis did not demonstrate an increase in survival. A 2011–2013 trial in spinal muscular atrophy (SMA) indicated that the compound may prevent deterioration of muscle function. In 2015, the entire olesoxime programme was purchased by Hoffmann-La Roche for €120 million with a view to developing a treatment for SMA. However, in June 2018, faced with technical and regulatory challenges and competition from a potentially more effective drug nusinersen, Roche halted further development of olesoxime.

References

Further reading

External links cholest-4-en-3-one, oxime at the U.S. National Library of Medicine Medical Subject Headings (MeSH)'

Illustrations

Olesoxime illustration

Worked examples

Example 1 — a first encounter with Olesoxime

Start with the simplest possible case. Write down what Olesoxime claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Olesoxime before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Olesoxime ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Olesoxime

In research
Olesoxime appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Olesoxime in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Olesoxime is common in secondary-school and first-year university syllabi. It links to neighbouring topics Cholestanes, Drugs developed by Hoffmann-La Roche, Drugs with unknown mechanisms of action, so understanding it makes those chapters shorter.
In everyday life
Look for Olesoxime outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Olesoxime” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Olesoxime in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Olesoxime means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Olesoxime out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Olesoxime in simple terms?

Olesoxime (TRO19622) is an experimental drug formerly under development by the now-defunct French company Trophos as a treatment for a range of neuromuscular disorders. It has a cholesterol-like structure and belongs to the cholesterol-oxime family of mitochondrial pore modulators.

Why does Olesoxime matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Olesoxime?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Olesoxime.

Tags

  • Cholestanes
  • Drugs developed by Hoffmann-La Roche
  • Drugs with unknown mechanisms of action
  • Ketoximes
  • Spinal muscular atrophy
  • TSPO ligands

Keep exploring